Dan Mitchell Joins ARCA biopharma Board Of Directors
2/12/2014 9:31:11 AM
WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Dan Mitchell has been appointed to the Company’s Board of Directors. He will serve on the Audit and Nominating and Corporate Governance Committees of the Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by